Page last updated: 2024-08-24

cilazapril, anhydrous and Ventricular Dysfunction, Left

cilazapril, anhydrous has been researched along with Ventricular Dysfunction, Left in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angomachalelis, N; Hourzamanis, AI; Serasli, E; Sideri, S; Vamvalis, C1
Hayashidani, S; Ide, T; Kinugawa, S; Suematsu, N; Takeshita, A; Tsutsui, H; Utsumi, H1

Other Studies

2 other study(ies) available for cilazapril, anhydrous and Ventricular Dysfunction, Left

ArticleYear
Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection.
    Heart and vessels, 1996, Volume: 11, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Cilazapril; Diastole; Echocardiography, Doppler; Female; Humans; Hypertension; Image Processing, Computer-Assisted; Male; Middle Aged; Time Factors; Ventricular Dysfunction, Left

1996
Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats.
    Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Electron Spin Resonance Spectroscopy; Heart Failure; Hypertrophy, Left Ventricular; Male; Oxidative Stress; Piperidines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium Chloride, Dietary; Survival Rate; Ventricular Dysfunction, Left

2001